Latest News

A new study from the Braddock Laboratory at Yale School of Medicine sheds light on the pathogenesis of two debilitating spinal disorders prevalent in the aging population – ossification of the posterior longitudinal ligament (OPLL) and diffuse idiopathic skeletal hyperostosis (DISH), and presents potential groundbreaking therapy.

A total of 18 orthopaedics & rehabilitation faculty members were named 2025 Health Care Research All-Stars by Avant-garde Health in a report that recognizes the outstanding physicians and hospitals whose contributions to health care research significantly enhance the quality of patient care.

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds. In the phase 3 clinical trial, people with osteoarthritis who dieted, exercised and took semaglutide — the blockbuster drug sold by Novo Nordisk as Ozempic and Wegovy — lost more weight and reported a greater reduction in knee pain than those who lost weight with just diet and exercise.

As students from the third academic cohort of the nation’s first master’s degree in personalized medicine and applied engineering (PMAE) progress through a unique curriculum, the program’s co-director, Daniel Wiznia, MD, explains why advanced technology is playing a growing role between medicine and engineering.

The Blavatnik Fund for Innovation at Yale Ventures has awarded a research grant award to an interdisciplinary team of Yale researchers for a project titled, “Dynamic 3D Morphometric Analysis.” The two-year $150,000 grant, funded through the Blavatnik Fund for Innovation, was awarded to associate research scientist, Frank Buono, PhD, associate professor, Daniel Wiznia, MD, and research scientist, Steven Tommasini, PhD, at the Yale Innovation Summit in recognition of their impact through life-science acceleration.

Frank Buono, PhD, associate research scientist in psychiatry; Jose Cortes-Briones, PhD, assistant professor of psychiatry; and Emily Lee, MD, assistant professor adjunct of psychiatry, have been chosen to receive a 2024 Blavatnik Award by Yale Ventures.

The Yale Center for Clinical Investigation (YCCI) has awarded a research pilot award to an interdisciplinary team of Yale researchers for a project titled, “Utilizing Machine Learning to Model the Volumetric Growth of Vestibular Schwannomas.”